Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07433634 · ClinicalTrials.gov registry record

Time to BBVNA Relief

A clinical trial of Low Back Pain and Vertebrogenic Pain Syndrome, sponsored by Yale University.

Recruiting
Registry status
200
Enrollment target
3
Study locations

NCT07433634 is a study of Low Back Pain and Vertebrogenic Pain Syndrome that is actively recruiting participants, run by Yale University. The registered enrollment target is 200 participants, below the 502-participant average among 122 other Low Back Pain trials with a reported enrollment target (60% lower). The trial reports 3 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07433634, a study of Low Back Pain and Vertebrogenic Pain Syndrome, is actively recruiting participants, sponsored by Yale University.

RECRUITING
Registry status
200 participants
Enrollment target
3
Study locations

Study Summary

Basivertebral nerve ablation (BVNA) is a minimally invasive procedure approved for vertebrogenic low back pain. While early studies support its efficacy, real-world evidence is still evolving, particularly regarding the trajectory of pain relief and functional improvement over time, and predictors of clinical response. This study aims to evaluate clinical outcomes longitudinally following BVNA and identify baseline predictors of response.

Interventions

  • PROCEDURE Basivertebral nerve ablation

Study Locations (3)

Connecticut

  • Yale Spine and Pain Center - Guilford - Guilford
  • Yale Pain Management Center - New Haven - New Haven
  • Yale Interventional Spine and Musculoskeletal Medicine - Old Saybrook - Old Saybrook

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2024-04-19
Est. Completion 2026-10

Sponsor

Yale University

1,492 total trials

What the Registry Record Tells You About NCT07433634

The ClinicalTrials.gov registry entry for NCT07433634 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 502-participant average among 122 other Low Back Pain trials with a reported enrollment target (60% lower). The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Low Back Pain appearing as the primary indexed condition, and to 1 intervention - of which Basivertebral nerve ablation is the first listed.

NCT07433634 reports 3 study locations spanning 1 distinct geographic area - top geographies include Connecticut.

Frequently Asked Questions

What is clinical trial NCT07433634 about?

NCT07433634 is a clinical study titled "Time to BBVNA Relief". Basivertebral nerve ablation (BVNA) is a minimally invasive procedure approved for vertebrogenic low back pain. While early studies support its efficacy, real-world evidence is still evolving, particularly regarding the trajectory of pain relief and functional improvement over time, and predictors o...

What is the current status of trial NCT07433634?

This trial is currently recruiting. The enrollment target is 200 participants. The study started on 2024-04-19. Estimated completion is 2026-10.

What conditions does trial NCT07433634 study?

This clinical trial studies the following conditions: Low Back Pain, Vertebrogenic Pain Syndrome, Basivertebral Nerve Ablation.

What interventions are being tested in trial NCT07433634?

The interventions under investigation include: Basivertebral nerve ablation (PROCEDURE).

Who is sponsoring clinical trial NCT07433634?

This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07433634 being conducted?

This trial has 3 study locations across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Low Back Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.